A phase I/II study of gilteritinib in combination with chemotherapy in newly diagnosed patients with AML in Asia: final analysis
Therapeutic Advances in Hematology
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#leukemia #combinationtherapy #cancer #oncology #openaccess